M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation
…, FJ O'Reilly, MA Wear, JR O'Neill… - Proceedings of the …, 2013 - National Acad Sciences
We show that the M2 isoform of pyruvate kinase (M2PYK) exists in equilibrium between
monomers and tetramers regulated by allosteric binding of naturally occurring small-molecule …
monomers and tetramers regulated by allosteric binding of naturally occurring small-molecule …
Risk prediction model of 90-day mortality after esophagectomy for cancer
…, SS Gisbertz, JR O'Neill… - JAMA …, 2021 - jamanetwork.com
Importance Ninety-day mortality rates after esophagectomy are an indicator of the quality of
surgical oncologic management. Accurate risk prediction based on large data sets may aid …
surgical oncologic management. Accurate risk prediction based on large data sets may aid …
Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts
…, V Save, RJE Skipworth, TR Hupp, JR O'Neill… - Gastroenterology, 2018 - Elsevier
Background & Aims Most patients with esophageal adenocarcinoma (EAC) present with de
novo tumors. Although this could be due to inadequate screening strategies, the precise …
novo tumors. Although this could be due to inadequate screening strategies, the precise …
Identification of subtypes of Barrett's esophagus and esophageal adenocarcinoma based on DNA methylation profiles and integration of transcriptome and genome …
…, V Save, RJE Skipworth, TR Hupp, JR O'Neill… - Gastroenterology, 2020 - Elsevier
Background & Aims Esophageal adenocarcinomas (EACs) are heterogeneous and often
preceded by Barrett’s esophagus (BE). Many genomic changes have been associated with …
preceded by Barrett’s esophagus (BE). Many genomic changes have been associated with …
Machine learning to predict early recurrence after oesophageal cancer surgery
…, S Mercer, EA Griffiths, JR O'Neill… - Journal of British …, 2020 - academic.oup.com
Background Early cancer recurrence after oesophagectomy is a common problem, with an
incidence of 20–30 per cent despite the widespread use of neoadjuvant treatment. …
incidence of 20–30 per cent despite the widespread use of neoadjuvant treatment. …
Multiparametric high-content cell painting identifies copper ionophores as selective modulators of esophageal cancer phenotypes
…, NJ Clemons, R Fitzgerald, JR O'neill… - ACS Chemical …, 2022 - ACS Publications
Esophageal adenocarcinoma is of increasing global concern due to increasing incidence, a
lack of effective treatments, and poor prognosis. Therapeutic target discovery and clinical …
lack of effective treatments, and poor prognosis. Therapeutic target discovery and clinical …
[HTML][HTML] The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Tumor antigens can emerge through multiple mechanisms, including translation of noncoding
genomic regions. This noncanonical category of tumor antigens has recently gained …
genomic regions. This noncanonical category of tumor antigens has recently gained …
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction
…, TR Hupp, J Robert O'Neill… - … journal of cancer, 2019 - Wiley Online Library
Cancers occurring at the gastroesophageal junction (GEJ) are classified as predominantly
esophageal or gastric, which is often difficult to decipher. We hypothesized that the …
esophageal or gastric, which is often difficult to decipher. We hypothesized that the …
High-content phenotypic profiling in esophageal adenocarcinoma identifies selectively active pharmacological classes of drugs for repurposing and chemical starting …
…, AF Munro, A Makda, JR O'Neill… - … the Science of Drug …, 2020 - journals.sagepub.com
Esophageal adenocarcinoma (EAC) is a highly heterogeneous disease, dominated by large-scale
genomic rearrangements and copy number alterations. Such characteristics have …
genomic rearrangements and copy number alterations. Such characteristics have …
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre-and post-chemotherapy
…, V Save, RJE Skipworth, TR Hupp, JR O'Neill… - Genome …, 2017 - genome.cshlp.org
The scientific community has avoided using tissue samples from patients that have been
exposed to systemic chemotherapy to infer the genomic landscape of a given cancer. …
exposed to systemic chemotherapy to infer the genomic landscape of a given cancer. …